Chronic total occlusion
Chronic Total Occlusion (CTO) is a coronary artery disease characterized by a heavy atherosclerotic plaque build-up within the coronary arteries, leading to a complete obstruction of blood flow for at least three months. This condition is a complex and challenging form of coronary artery disease that is often associated with a poor prognosis and a high risk of myocardial infarction or heart attack.
Definition[edit | edit source]
A Chronic Total Occlusion is defined as a coronary obstruction that prevents any blood flow to a section of the heart for three months or longer. The obstruction is typically caused by a build-up of atherosclerotic plaque, which hardens over time and completely blocks the artery.
Epidemiology[edit | edit source]
CTOs are found in approximately 15-30% of patients with significant coronary artery disease. They are more common in older patients, males, and those with a history of myocardial infarction, diabetes, or peripheral vascular disease.
Pathophysiology[edit | edit source]
The pathophysiology of CTO is complex and involves the accumulation of atherosclerotic plaque within the coronary arteries. This plaque hardens over time, leading to a complete obstruction of the artery. The lack of blood flow to the heart muscle can result in ischemia, or insufficient oxygen supply to the heart, which can lead to symptoms such as chest pain or angina.
Diagnosis[edit | edit source]
The diagnosis of CTO is typically made through coronary angiography, a procedure that uses X-ray imaging to visualize the coronary arteries. Other diagnostic tests may include electrocardiogram (ECG), stress testing, and cardiac MRI.
Treatment[edit | edit source]
The treatment of CTO is challenging and depends on the patient's symptoms, overall health, and the location and extent of the occlusion. Treatment options may include medication therapy, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG).
Prognosis[edit | edit source]
The prognosis for patients with CTO is variable and depends on several factors, including the patient's overall health, the extent of the occlusion, and the success of treatment. However, with appropriate treatment, many patients can experience significant improvements in symptoms and quality of life.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD